Noncompaction cardiomyopathy holter monitoring

Jump to navigation Jump to search

Noncompaction Cardiomyopathy Microchapters

Home

Patient Info

Overview

Historical Perspective

Classification & Nomenclature

Pathophysiology

Genetics
Embryology
Histology
Left Ventricular Dysfunction
Arrhythmias
Thromboembolism
Neuromuscular Disorders

Epidemiology & Demographics

Screening

Natural History, Complications & Prognosis

Differentiating Noncompaction Cardiomyopathy from other Diseases

Diagnosis

History & Symptoms

Physical Examination

Laboratory Studies

Genetic Testing

Electrocardiogram

Holter Monitoring

Chest X Ray

MRI

CT

Echocardiography

Biopsy

Treatment

Medical Therapy

Surgery

Noncompaction cardiomyopathy holter monitoring On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Noncompaction cardiomyopathy holter monitoring

CDC on Noncompaction cardiomyopathy holter monitoring

Noncompaction cardiomyopathy holter monitoring in the news

Blogs on Noncompaction cardiomyopathy holter monitoring

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Noncompaction cardiomyopathy holter monitoring

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

The use of a looping ECG event recorder or Holter monitor can be very useful in ascertaining the frequency of atrial fibrillation and the rapidity of the ventricular response. It is also useful in gauging the frequency of ventricular tachycardia. This information can be used to guide treatment including pharmacotherapy and the need for automatic implantable cardiac defibrillator implantation[1].

References

  1. Weiford BC, Subbarao VD, Mulhern KM (2004). "Noncompaction of the ventricular myocardium". Circulation. 109 (24): 2965–71. doi:10.1161/01.CIR.0000132478.60674.D0. PMID 15210614.